Bruno Geloneze

Cited by

	All	Since 2019
Citations	44745	29372
h-index	54	36
i10-index	120	87

7000

3500

1750

5250

20082009201020112012201320142015201620172018201920202021202220232024177 265 307 399 567 704 750 878 2271 3505 4248 4562 5801 6257 5715 5232 1664

Public access

View all

13 articles

2 articles

available

not available

Based on funding mandates

Co-authors

Jose Carlos ParejaUniversidade Estadual de CampinasVerified email at obesidadesevera.com.br
Elinton ChaimUniversidade Estadual de CampinasVerified email at hc.unicamp.br
LICIO Augusto VellosoProfessor of Medicine, University of CampinasVerified email at unicamp.br
Mario José Abdalla SaadProfessor Titular da Faculdade de Ciências Médicas - FCM, UNICAMPVerified email at fcm.unicamp.br
Everton CazzoProfessor Associado Livre Docente; Universidade Estadual de CampinasVerified email at unicamp.br
Gil Guerra-JuniorUNICAMPVerified email at fcm.unicamp.br
Eliete BouskelaProfessora Titular de Fisiologia Cardiovascular, Universidade do Estado do Rio de JaneiroVerified email at pq.cnpq.br
Foued Salmen EspindolaUniversidade Federal de UberlândiaVerified email at ufu.br
Adriana Aparecida Siviero-MiachonProfessora Adjunta, Departamento de Pediatria, Universidade Federal de São Paulo - UNIFESP/EPMVerified email at unifesp.br
Angela Maria Spinola e CastroUniversidade Federal de São PauloVerified email at angelaspinola.com.br
MARCIO CORRÊA ManciniHead of the Obesity and Metabolic Syndrome Unit at the Department of Endocrinology and MetabolismVerified email at hc.fm.usp.br
Fernando CendesFull Professor, Department of Neurology, FCM, University of Campinas - UNICAMPVerified email at unicamp.br
Celia Regina GarlippUniversidade Estadual de CampinasVerified email at hc.unicamp.br
Rita de Cássia Gonçalves AlfenasProfessor de Nutrição, Universidade Federal de ViçosaVerified email at ufv.br
Dioze GuadagniniUNICAMPVerified email at fcm.unicamp.br
Marciane MilanskiProfessora do Curso de Nutrição, Faculdade de Ciências Aplicadas - UnicampVerified email at fca.unicamp.br
luciana mela UmedaUniversidade Federal de São PauloVerified email at unifesp.br
Li Min LiProfessor of Neurology, Faculty of Medical Sciences at University of CampinasVerified email at fcm.unicamp.br
PAULA TEIXEIRA FERNANDESPROFESSOR OF PHYSICAL EDUCATION, STATE UNIVERSITY OF CAMPINASVerified email at fef.unicamp.br
Fabricio PereiraUniversity of NimesVerified email at affiliate.mcgill.ca

Bruno Geloneze

Professor of Endocrinology and Diabetes, Obesity and Comorbities Research Center UNICAMP Brazil

Verified email at unicamp.br

Endocrinology Diabetes Obesity Bariatric Surgery GLP-1


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes ISE Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus ... New England Journal of Medicine 373 (22), 2117-28, 2015	12401	2015
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes M SP, D GH, Brown-Frandsen K, K P, M JF, N MA, N SE, P S, P NR, R LS, ... New England Journal of Medicine 375 (4), 311-322, 2016	7077	2016
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy MKW Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM ... New England Journal of Medicine 380 (24), 2295-2306, 2019	4968	2019
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. MM Wanner C1, Inzucchi SE1, Lachin JM1, Fitchett D1, von Eynatten M1, ... New England Journal of Medicine 375 (4), 323-334, 2016	3830	2016
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. WJP Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau ... New England Journal of Medicine 373 (1), 11-22, 2015	2096	2015
Liraglutide and Renal Outcomes in Type 2 Diabetes BJB Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S ... New England Journal of Medicine 377 (9), 839-848, 2017	1177	2017
Pratical recommendations for the management of diabetes in patients with COVID-19 SR Bernstein, F Rubino, K Khunti, G Mingrone, D Hopkins, AL Birkenfeld, ... The Lancet Diabetes & Endocrinology, 00, 2020	1060	2020
IV Diretriz brasileira sobre dislipidemias e prevenção da aterosclerose: Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia AC Sposito, B Caramelli, FAH Fonseca, MC Bertolami, A Afiune Neto, ... Arquivos brasileiros de cardiologia 88, 2-19, 2007	989*	2007
Long-term weight regain after gastric bypass: a 5-year prospective study DO Magro, B Geloneze, R Delfini, BC Pareja, F Callejas, JC Pareja Obesity surgery 18 (6), 648-651, 2008	839	2008
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. PSX le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DC, Van Gaal L, Ortiz ... Lancet 140 (17), 30069-7, 2017	710*	2017
The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 … MLMP Jorge, VN de Oliveira, NM Resende, LF Paraiso, A Calixto, ... Metabolism 60 (9), 1244-1252, 2011	628	2011
I Diretriz sobre o consumo de gorduras e saúde cardiovascular RD Santos, ACM Gagliardi, HT Xavier, CD Magnoni, R Cassani, ... Arquivos Brasileiros de Cardiologia 100, 1-40, 2013	606	2013
TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study ACJ Vasques, FS Novaes, MS de Oliveira, JRM Souza, A Yamanaka, ... Diabetes research and clinical practice 93 (3), e98-e100, 2011	482	2011
HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS) B Geloneze, ACJ Vasques, CFC Stabe, JC Pareja, LEFP Rosado, ... Arquivos Brasileiros de Endocrinologia & Metabologia 53 (2), 281-287, 2009	413	2009
Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26 … BMK Russell-Jones D, Cuddihy RM, Hanefeld M, Kumar A, González JG, Chan M ... Diabetes Care 35 (2), 252-8, 2012	402	2012
The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. B Geloneze, EM Repetto, SR Geloneze, MA Tambascia, MN Ermetice Diabetes Research and Clinical Practice 72 (2), 219, 2006	337	2006
Neck Circumference as a Simple Tool for Identifying the Metabolic Syndrome and Insulin Resistance: Results from the Brazilian Metabolic Syndrome Study (BRAMS) C Stabe, ACJ Vasques, MMO Lima, MA Tambascia, JC Pareja, ... Clinical Endocrinology, 2012	320	2012
Ghrelin: a gut-brain hormone: effect of gastric bypass surgery B Geloneze, MA Tambascia, VF Pilla, SR Geloneze, EM Repetto, ... Obesity surgery 13 (1), 17-22, 2003	254	2003
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics PV Jardine MJ, Mahaffey KW, Neal B, Agarwal R, Bakris GL, Brenner BM, Bull S ... American Journalof Nephrology 46 (6), 462-472, 2017	246*	2017
Avaliação laboratorial e diagnóstico da resistência insulínica; Laboratorial evaluation and diagnosis of insulin resistance B Geloneze, MA Tambascia Arq. bras. endocrinol. metab 50 (2), 208-215, 2006	233	2006

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors